Rhinorrhea After Cabergoline Treatment for Giant Invasive Macroprolactinoma: A Case Report
نویسندگان
چکیده
منابع مشابه
Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
Cerebrospinal fluid (CSF) rhinorrhea is rarely reported as the first presenting feature of giant invasive macroprolactinomas. Cerebrospinal fluid rhinorrhea is usually reported as a complication of trauma, neurosurgical, and skull-based procedures (such as pituitary surgery or radiations), and less frequently after medical treatment with dopamine agonists (DAs) for macroprolactinomas. This phen...
متن کاملPneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
A 43-year-old male trisomic patient was referred for acute left headache and progressive homolateral mydriasis and ptosis. Computed tomography and T2-magnetic resonance imaging demonstrated a 4 cm invasive pituitary adenoma (Panels A and C, respectively). Blood analyses revealed hyperprolactinemia (5460 ng/ml, normal values < 15 ng/ml) and severe gonadotrophic insuffi ciency. Treatment was clas...
متن کاملCabergoline Treatment in Invasive Giant Prolactinoma
Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline tr...
متن کاملHyperthyroidism unmasked several years after the medical and radiosurgical treatment of an invasive macroprolactinoma inducing hypopituitarism: a case report
INTRODUCTION Measuring thyroid stimulating hormone levels alone may be insufficient to appropriately evaluate thyroid function. Reduced thyroid stimulating hormone levels associated to normal/reduced FT4 levels should prompt investigation of pituitary function, on suspicion of hypopituitarism. Pituitary macroadenomas are the most common cause of hypopituitarism; among these, macroprolactinomas ...
متن کاملCabergoline for Cushing's disease: A case report.
como la mayor dosificación (> 400 mg/día) podría favorecer la aparición de un síndrome de Cushing11. En consecuencia, debe tenerse especial precaución al utilizar AM por su acción sobre el eje del cortisol, dada la posibilidad de producirse, en un mismo paciente, un síndrome de Cushing y una IS posterior al retirar el AM bruscamente12. En conclusión, dado que el AM es un fármaco comúnmente util...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Turkish Journal of Endocrinology and Metabolism
سال: 2018
ISSN: 1301-2193,1308-9846
DOI: 10.25179/tjem.20182202-p065